Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Deficient Apoptosis Signaling in Primary Pediatric BCP-ALL Xenograft Cells Determines the Kinetic of Engraftment in Vivo in a NOD/SCID Model and Patient Outcome

Manon Queudeville, MD, Sarah M. Eckhoff, MD, Karsten Stahnke, MD, Klaus-Michael Debatin, MD, Lueder H. Meyer, MD

Blood (2008) 112 (11): 2509.

https://doi.org/10.1182/blood.V112.11.2509.2509

Published: 2008

Journal Articles

Intact apoptosis signaling in myeloid leukemia cells determines treatment outcome in childhood AML

Lüder H. Meyer, Manon Queudeville, Sarah M. Eckhoff, Ursula Creutzig, Dirk Reinhardt, Leonid Karawajew, Wolf-Dieter Ludwig, Karsten Stahnke, Klaus-Michael Debatin

Blood (2008) 111 (5): 2899–2903.

https://doi.org/10.1182/blood-2007-08-109058

Published: 2008

Includes: Supplemental data

Journal Articles

Favourable Treatment Outcome in Childhood AML Is Determined by Intact Apoptosis Signalling in Myeloid Leukaemia Cells.

Lüder H. Meyer, MD, Manon Dammé, Sarah M. Eckhoff, MD, Ursula Creutzig, MD, Dirk Reinhardt, MD, Leonid Karawajew, PhD, Wolf D. Ludwig, MD, Karsten Stahnke, MD, Klaus M. Debatin, MD

Blood (2007) 110 (11): 2842.

https://doi.org/10.1182/blood.V110.11.2842.2842

Published: 2007

Journal Articles

Time to Leukaemia (TTL) Assessed in NOD/SCID Mice Transplanted with Primary ALL Leukaemia Cells Determines Early Relapse in Patients and Is Identified by a Specific Gene Signature.

Lüder H. Meyer, MD, Sarah M. Eckhoff, MD, Manon Dammé, Martin Zimmermann, PhD, André Schrauder, MD, Georgia Lahr, PhD, Karsten Stahnke, MD, Martin Schrappe, MD, Klaus M. Debatin, MD

Blood (2007) 110 (11): 726.

https://doi.org/10.1182/blood.V110.11.726.726

Published: 2007

Journal Articles

Cytochrome c–related caspase-3 activation determines treatment response and relapse in childhood precursor B-cell ALL

Lüder Hinrich Meyer, Leonid Karawajew, Martin Schrappe, Wolf-Dieter Ludwig, Klaus-Michael Debatin, Karsten Stahnke

Blood (2006) 107 (11): 4524–4531.

https://doi.org/10.1182/blood-2005-08-3305

Published: 2006

Includes: Supplemental data

Journal Articles

Cytochrome C Related Caspase Activation Determines Treatment Response in Childhood B- Precursor ALL.

Lueder H. Meyer, Leonid Karawajew, Martin Schrappe, Wolf D. Ludwig, Klaus M. Debatin, Karsten Stahnke

Blood (2004) 104 (11): 990.

https://doi.org/10.1182/blood.V104.11.990.990

Published: 2004

Journal Articles

Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy

Karsten Stahnke, Simone Fulda, Claudia Friesen, Gudrun Strauß, Klaus-Michael Debatin

Blood (2001) 98 (10): 3066–3073.

https://doi.org/10.1182/blood.V98.10.3066

Published: 2001

NARROW

Deficient Apoptosis Signaling in Primary Pediatric BCP-ALL Xenograft Cells Determines the Kinetic of Engraftment in Vivo in a NOD/SCID Model and Patient Outcome

Intact apoptosis signaling in myeloid leukemia cells determines treatment outcome in childhood AML

Favourable Treatment Outcome in Childhood AML Is Determined by Intact Apoptosis Signalling in Myeloid Leukaemia Cells.

Time to Leukaemia (TTL) Assessed in NOD/SCID Mice Transplanted with Primary ALL Leukaemia Cells Determines Early Relapse in Patients and Is Identified by a Specific Gene Signature.

Cytochrome c–related caspase-3 activation determines treatment response and relapse in childhood precursor B-cell ALL

Cytochrome C Related Caspase Activation Determines Treatment Response in Childhood B- Precursor ALL.

Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Deficient Apoptosis Signaling in Primary Pediatric BCP-ALL Xenograft Cells Determines the Kinetic of Engraftment in Vivo in a NOD/SCID Model and Patient Outcome

Intact apoptosis signaling in myeloid leukemia cells determines treatment outcome in childhood AML

Favourable Treatment Outcome in Childhood AML Is Determined by Intact Apoptosis Signalling in Myeloid Leukaemia Cells.

Time to Leukaemia (TTL) Assessed in NOD/SCID Mice Transplanted with Primary ALL Leukaemia Cells Determines Early Relapse in Patients and Is Identified by a Specific Gene Signature.

Cytochrome c–related caspase-3 activation determines treatment response and relapse in childhood precursor B-cell ALL

Cytochrome C Related Caspase Activation Determines Treatment Response in Childhood B- Precursor ALL.

Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only